Taking common painkillers during pregnancy more often is likely to raise the risk of autism and attention-deficit hyperactivity disorder (ADHD) in children, especially boys, new research warns.
The findings also showed that pre-natal exposure to paracetamol raises the risk of autism spectrum diseases more in boys.
"The male brain may be more vulnerable to harmful influences during early life. Our differing gender results suggest that androgenic endocrine disruption, to which male brains could be more sensitive, may explain the association," lead author Claudia Avella-Garcia, researcher at Centre for Research in Environmental Epidemiology (CREAL), a Spanish research organisation.
On the other hand, maternal intake of paracetamol increased the risk of ADHD in children of both genders.
Persistently exposed children in particular showed poorer performance in attention, impulsivity and visual speed processing.
"An increase in the number of symptoms that a child has, can affect him or her, even if they are not severe enough to warrant a clinical diagnosis of a neurodevelopmental disorder," Avella-Garcia added.
The exposed children were at higher risk of hyperactivity or impulsivity symptoms at age five.
For the study, published in the International Journal of Epidemiology, the team recruited 2,644 mother-child pairs in a birth cohort study during pregnancy.
Paracetamol could be harmful to neurodevelopment for several reasons.
First of all, it relieves pain by acting on cannabinoid receptors in the brain.
Since these receptors normally help determine how neurons mature and connect with one another, paracetamol could alter these important processes, the researchers explained.
"It can also affect the development of the immune system, or be directly toxic to some foetuses that may not have the same capacity as an adult to metabolise this drug, or by creating oxidative stress," noted Jordi Julvez, one of the researchers from CREAL.
--IANS
rt/ask/vm
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
